Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ClearPoint Neuro Inc. - Common Stock
(NQ:
CLPT
)
13.41
+1.22 (+10.01%)
Streaming Delayed Price
Updated: 12:59 PM EDT, May 14, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about ClearPoint Neuro Inc. - Common Stock
< Previous
1
2
Next >
ClearPoint Neuro Reports First Quarter 2026 Results
May 13, 2026
Via
ACCESS Newswire
ClearPoint Neuro Announces CE Marking of Velocity Alpha MR High Speed Surgical Drill System, Further Expanding Drug Delivery Ecosystem and Global Footprint
May 13, 2026
Via
ACCESS Newswire
ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026
April 29, 2026
Via
ACCESS Newswire
ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
April 22, 2026
Via
ACCESS Newswire
ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint
April 20, 2026
Via
ACCESS Newswire
ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results
February 26, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
November 13, 2024
Via
ACCESSWIRE
ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results
March 17, 2026
Via
ACCESS Newswire
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026
March 06, 2026
Via
ACCESS Newswire
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
January 12, 2026
Via
ACCESS Newswire
ClearPoint Neuro Completes Acquisition of IRRAS
November 20, 2025
Via
ACCESS Newswire
ClearPoint Neuro Reports Third Quarter 2025 Results
November 06, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Agreement to Acquire IRRAS
November 06, 2025
Via
ACCESS Newswire
ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025
November 05, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles
October 07, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide
October 06, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System
October 01, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
September 25, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
September 04, 2025
Via
ACCESS Newswire
ClearPoint Neuro Reports Second Quarter 2025 Results
August 12, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio
August 04, 2025
Via
ACCESS Newswire
ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025
July 23, 2025
Via
ACCESS Newswire
ClearPoint Neuro Reports First Quarter 2025 Results
May 13, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Investment of up to $110 Million by Oberland Capital with $33.5 Million Funded at Closing
May 12, 2025
Via
ACCESS Newswire
ClearPoint Neuro, Together with its Partner Clinical Laserthermia Systems, Announces FDA Submission to Expand the Labeling of ClearPoint Prism(R) to Include 1.5 T MRI
April 28, 2025
Via
ACCESS Newswire
ClearPoint Neuro to Announce First Quarter 2025 Results May 13, 2025
April 25, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 – Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room
April 24, 2025
Via
ACCESS Newswire
ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025
February 14, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula
February 12, 2025
Via
ACCESS Newswire
ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.0
January 27, 2025
Via
ACCESS Newswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
